Cagrilintide

Weight Loss

Chemical Information:

• Chemical Name: Cagrilintide
• Compound Type: Long-acting amylin analogue peptide
• Molecular Formula: C₁₆₀H₂₅₃N₄₅O₄₈S (approximate; depends on specific peptide modifications)
• Molecular Weight: ~3,700–3,800 g/mol (varies with exact sequence and modifications)
• Peptide Class: Synthetic amylin analogue, designed for extended stability and metabolic research

Description:

Cagrilintide is a long-acting peptide designed to replicate the function of amylin, a hormone co-secreted with insulin by pancreatic beta cells. Naturally, amylin helps regulate appetite, delays gastric emptying, and contributes to glucose and energy balance. Due to rapid enzymatic degradation, native amylin has limited clinical utility. Cagrilintide overcomes this through molecular modifications that enhance stability and extend its half-life, enabling convenient once-weekly subcutaneous administration in clinical protocols.

Research Applications:

• Appetite and Satiety Modulation: Evaluating Cagrilintide’s effects on hypothalamic and gut-mediated satiety signaling, meal frequency, and caloric intake.
• Gastrointestinal Kinetics: Investigating delayed gastric emptying and its impact on postprandial glucose excursions and nutrient absorption.
• Metabolic and Endocrine Research: Studying effects on energy homeostasis, insulin-glucose dynamics, and lipid metabolism.
• Combination Pharmacotherapy Studies: Assessing synergistic interactions with GLP-1 receptor agonists (e.g., semaglutide) for enhanced weight loss and metabolic regulation.

Storage and Handling:

• Store at –20°C (frozen) for long-term stability; short-term storage at 2–8°C is acceptable if used promptly.
• Maintain tightly sealed in original vials to avoid contamination and moisture exposure.
• Use aseptic techniques and appropriate laboratory safety protocols when preparing or administering research doses.

Compliance Notice:

Cagrilintide is intended strictly for research and clinical investigation purposes and is not approved for general human or veterinary use. This product has not been evaluated by the FDA or any other regulatory authority. Any unauthorized use is prohibited and may be subject to applicable laws. By purchasing, the buyer confirms that Cagrilintide will be used solely for controlled laboratory or physician-supervised research studies.